Table 1:	Incidence of Treatment-Emergent Adverse Events Reported in at Least 5% of Subjects in Either Treatment Group, by System Organ Class and Preferred Term
#1||NULL||Drug A (N=791)||Placebo (N=394)
#1||NULL||Total || Total
#1||Number of subjects with a treatment-emergent adverse event||782 (98.9%)||390 (99.0%)
#1||System organ class/preferred term||NULL||NULL
#1||Musculoskeletal and connective tissue disorders||576 (72.8%)||291 (73.9%)
#2||Back pain||233 (29.5%)||129 (32.7%)
#2||Arthralgia||215 (27.2%)||89 (22.6%)
#2||Bone pain||194 (24.5%)||110 (27.9%)
#2||Pain in extremity||134 (16.9%)||79 (20.1%)
#2||Musculoskeletal pain||117 (14.8%)||51 (12.9%)
#2||Muscular weakness||80 (10.1%)||35 (8.9%)
#2||Muscle spasms||68 (8.6%)||37 (9.4%)
#2||Groin pain||43 (5.4%)||22 (5.6%)
#1||General disorders and administration site conditions||549 (69.4%)||262 (66.5%)
#2||Fatigue||346 (43.7%)||169 (42.9%)
#2||Oedema peripheral||197 (24.9%)||68 (17.3%)
#2||Asthenia||104 (13.1%)||52 (13.2%)
#2||Pyrexia||71 (9.0%)||35 (8.9%)
#1||Gastrointestinal disorders||531 (67.1%)||264 (67.0%)
#2||Nausea||233 (29.5%)||124 (31.5%)
#2||Constipation||206 (26.0%)||120 (30.5%)
#2||Vomiting||168 (21.2%)||97 (24.6%)
#2||Diarrhoea||139 (17.6%)||53 (13.5%)
#2||Abdominal pain||95 (12.0%)||44 (11.2%)
#2||Dry mouth||55 (7.0%)||21 (5.3%)
#2||Dyspepsia||48 (6.1%)||13 (3.3%)
#1||Metabolism and nutrition disorders||365 (46.1%)||164 (41.6%)
#2||Hypokalaemia||135 (17.1%)||33 (8.4%)
#2||Anorexia||131 (16.6%)||72 (18.3%)
#2||Decreased appetite||75 (9.5%)||34 (8.6%)
#2||Hyperglycaemia||48 (6.1%)||19 (4.8%)
#1||Nervous system disorders||339 (42.9%)||178 (45.2%)
#2||Headache||94 (11.9%)||42 (10.7%)
#2||Dizziness||75 (9.5%)||38 (9.6%)
#2||Spinal cord compression||28 (3.5%)||20 (5.1%)
#1||Infections and infestations||328 (41.5%)||134 (34.0%)
#2||Urinary tract infection||91 (11.5%)||28 (7.1%)
#2||Nasopharyngitis||45 (5.7%)||24 (6.1%)
#2||Upper respiratory tract infection||43 (5.4%)||10 (2.5%)
#1||Respiratory, thoracic and mediastinal disorders||267 (33.8%)||116 (29.4%)
#2||Dyspnoea||102 (12.9%)||46 (11.7%)
#2||Cough||84 (10.6%)||30 (7.6%)
#1||Vascular disorders||247 (31.2%)||123 (31.2%)
#2||Hot flush||150 (19.0%)||66 (16.8%)
#2||Hypertension||67 (8.5%)||27 (6.9%)
#1||Investigations||242 (30.6%)||105 (26.6%)
#2||Weight decreased||84 (10.6%)||55 (14.0%)
#1||Renal and urinary disorders||240 (30.3%)||111 (28.2%)
#2||Haematuria||65 (8.2%)||31 (7.9%)
#2||Pollakiuria||57 (7.2%)||20 (5.1%)
#2||Nocturia||49 (6.2%)||16 (4.1%)
#1||Blood and lymphatic system disorders||210 (26.5%)||116 (29.4%)
#2||Anaemia||178 (22.5%)||104 (26.4%)
#1||Psychiatric disorders||194 (24.5%)||104 (26.4%)
#2||Insomnia||82 (10.4%)||50 (12.7%)
#2||Anxiety||45 (5.7%)||21 (5.3%)
#2||Depression||37 (4.7%)||20 (5.1%)
#1||Injury, poisoning and procedural complications||174 (22.0%)||56 (14.2%)
#2||Contusion||53 (6.7%)||21 (5.3%)
#1||Reproductive system and breast disorders||41 (5.2%)||39 (9.9%)
#2||Pelvic pain||17 (2.1%)||22 (5.6%)

